| |
|
|
|
Immune Pharmaceuticals Inc
|
|
1.15 +0.03 (+2.68%) |
9/22/2017 4:00pm |
|
Open: |
1.15 |
Pre close: |
1.12 |
Target:
|
2.36
|
|
High: |
1.15 |
Low: |
1.08 |
Resistance:
|
2.02
2.64
|
|
Volume: |
332,360 |
Market Cap: |
12.16M |
Support:
|
1.01
0.84
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.09
 |
MACD |
MACD(12,26):
|
-0.13 |
|
MA(20): |
1.14  |
Signal(12,26,9): |
-0.17 |
|
MA(100): |
2.13 |
Stochastic Oscillator |
%K(14,3):
|
26.30 |
|
MA(250): |
1.11 |
%D(3): |
19.60 |
|
Average Volume(K) |
3-Month: |
64242
|
52-Week |
High:
|
5.02 |
|
10-Days: |
16810 |
Low: |
0.12 |
|
RSI |
RSI(14):
|
41.63 |
Change(%): |
290.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-4.740 |
Return on Equity (ttm) |
-593.8 |
Shares Out. (M) |
10.58 |
|
EPS Est. Current Year |
-0.620 |
Return on Assets (ttm) |
-29.6 |
Shares Float (M) |
9.36 |
|
EPS Est. Next Year |
0.170 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.26 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
5.00 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
678 |
|
Book Value (p.s.) |
-0.010 |
EBITDA (p.s.) |
-1.180 |
P/E |
-0.24 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-113.10 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.85 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-6.50 |
P/CF |
-1.10 |
|
|
|
|
|
|
|
